SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies

doi:10.1038/s41591-021-01347-0

. 2021 May;27(5):759-761.

doi: 10.1038/s41591-021-01347-0.

SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies

Emanuele Andreano¹, Rino Rappuoli^{2

3}

Affiliations

¹ Monoclonal Antibody Discovery Lab, , Fondazione Toscana Life Sciences, Siena, Italy.
² Monoclonal Antibody Discovery Lab, , Fondazione Toscana Life Sciences, Siena, Italy. rino.r.rappuoli@gsk.com.
³ Faculty of Medicine, Imperial College London, London, UK. rino.r.rappuoli@gsk.com.

PMID: 33972793
DOI: 10.1038/s41591-021-01347-0

SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies

Emanuele Andreano et al. Nat Med. 2021 May.

. 2021 May;27(5):759-761.

doi: 10.1038/s41591-021-01347-0.

Authors

Emanuele Andreano¹, Rino Rappuoli^{2

3}

Affiliations

¹ Monoclonal Antibody Discovery Lab, , Fondazione Toscana Life Sciences, Siena, Italy.
² Monoclonal Antibody Discovery Lab, , Fondazione Toscana Life Sciences, Siena, Italy. rino.r.rappuoli@gsk.com.
³ Faculty of Medicine, Imperial College London, London, UK. rino.r.rappuoli@gsk.com.

PMID: 33972793
DOI: 10.1038/s41591-021-01347-0

No abstract available

PubMed Disclaimer

Cited by

Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19.
Parihar A, Sonia ZF, Akter F, Ali MA, Hakim FT, Hossain MS. Parihar A, et al. Comput Biol Med. 2022 Jun;145:105468. doi: 10.1016/j.compbiomed.2022.105468. Epub 2022 Mar 30. Comput Biol Med. 2022. PMID: 35390745 Free PMC article.
Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations?
Kanakan A, Mehta P, Devi P, Saifi S, Swaminathan A, Maurya R, Chattopadhyay P, Tarai B, Das P, Jha V, Budhiraja S, Pandey R. Kanakan A, et al. Front Microbiol. 2022 Mar 3;13:763169. doi: 10.3389/fmicb.2022.763169. eCollection 2022. Front Microbiol. 2022. PMID: 35308382 Free PMC article.
N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.
Singh Y, Fuloria NK, Fuloria S, Subramaniyan V, Meenakshi DU, Chakravarthi S, Kumari U, Joshi N, Gupta G. Singh Y, et al. J Med Virol. 2021 Oct;93(10):5726-5728. doi: 10.1002/jmv.27181. Epub 2021 Jul 14. J Med Virol. 2021. PMID: 34232521 Free PMC article. No abstract available.
Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines.
Beeraka NM, Sukocheva OA, Lukina E, Liu J, Fan R. Beeraka NM, et al. Rev Med Virol. 2022 Sep;32(5):e2346. doi: 10.1002/rmv.2346. Epub 2022 Apr 13. Rev Med Virol. 2022. PMID: 35416390 Free PMC article. Review.
Analysis of co-occurring and mutually exclusive amino acid changes and detection of convergent and divergent evolution events in SARS-CoV-2.
Al Khalaf R, Bernasconi A, Pinoli P, Ceri S. Al Khalaf R, et al. Comput Struct Biotechnol J. 2022;20:4238-4250. doi: 10.1016/j.csbj.2022.07.051. Epub 2022 Aug 5. Comput Struct Biotechnol J. 2022. PMID: 35945925 Free PMC article.

See all "Cited by" articles

References

1. Chen, R. E. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01294-w (2021). - DOI - PubMed - PMC
1. Wibmer, C. K. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01285-x (2021). - DOI - PubMed
1. Xie, X. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01270-4 (2021). - DOI - PubMed - PMC
1. Planas, D. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01318-5 (2021). - DOI - PubMed
1. Andreano, E. et al. Cell 184, 1–15 (2021). - DOI

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Chen, R. E. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01294-w (2021). - DOI - PubMed - PMC

[2] Chen, R. E. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01294-w (2021). - DOI - PubMed - PMC

[3] Wibmer, C. K. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01285-x (2021). - DOI - PubMed

[4] Wibmer, C. K. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01285-x (2021). - DOI - PubMed

[5] Xie, X. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01270-4 (2021). - DOI - PubMed - PMC

[6] Xie, X. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01270-4 (2021). - DOI - PubMed - PMC

[7] Planas, D. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01318-5 (2021). - DOI - PubMed

[8] Planas, D. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01318-5 (2021). - DOI - PubMed

[9] Andreano, E. et al. Cell 184, 1–15 (2021). - DOI

[10] Andreano, E. et al. Cell 184, 1–15 (2021). - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies

Affiliations

SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies

Authors

Affiliations

Similar articles

Cited by

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous